Aging and Disease

Scope & Guideline

Innovating solutions for aging-related challenges.

Introduction

Welcome to your portal for understanding Aging and Disease, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2152-5250
PublisherINT SOC AGING & DISEASE
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2010 to 2024
AbbreviationAGING DIS / Aging Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106

Aims and Scopes

The journal 'Aging and Disease' focuses on advancing knowledge in the fields of aging and age-related diseases through a multidisciplinary approach, integrating basic science, clinical research, and therapeutic strategies.
  1. Age-Related Molecular Mechanisms:
    The journal emphasizes research on the molecular and cellular mechanisms underlying aging, including studies on oxidative stress, mitochondrial dysfunction, and cellular senescence.
  2. Chronic Diseases and Aging:
    A significant focus is placed on the relationship between aging and chronic diseases such as Alzheimer's disease, cardiovascular diseases, and diabetes, exploring their pathophysiology and potential interventions.
  3. Therapeutic Interventions and Innovations:
    The journal highlights novel therapeutic approaches and interventions aimed at mitigating age-related decline, including pharmacological treatments, stem cell therapies, and lifestyle modifications.
  4. Translational Research and Clinical Studies:
    Research that bridges the gap between laboratory findings and clinical applications is a core aspect, with studies designed to inform clinical practice for aging populations.
  5. Public Health and Aging:
    The journal also addresses public health issues related to aging, including epidemiological studies, healthcare policies, and the impact of socio-environmental factors on aging.
Recent publications in 'Aging and Disease' reveal several emerging themes that are gaining traction, indicating the direction of future research in the field.
  1. Microbiome and Aging:
    The relationship between the gut microbiome and aging is increasingly prominent, with studies exploring how microbiota influences age-related diseases and overall health.
  2. Cellular Senescence and its Implications:
    Research on cellular senescence, particularly its role in aging and chronic diseases, is rapidly expanding, highlighting its potential as a therapeutic target.
  3. Neuroinflammation and Cognitive Decline:
    There is a growing focus on the role of neuroinflammation in cognitive decline and neurodegenerative diseases, suggesting new avenues for intervention.
  4. Machine Learning and AI in Aging Research:
    The integration of machine learning and artificial intelligence in analyzing aging-related data is emerging as a critical area, promising to enhance predictive models and therapeutic strategies.
  5. Interdisciplinary Approaches to Aging:
    An increase in interdisciplinary studies that combine insights from genetics, epigenetics, neuroscience, and public health reflects a holistic view of aging research.

Declining or Waning

While 'Aging and Disease' continues to grow in various areas, some themes have shown a decline in prominence, reflecting shifts in research interests and funding.
  1. Traditional Pharmacological Approaches:
    There is a notable decrease in studies focusing solely on traditional pharmacological interventions without considering holistic or integrative approaches to aging.
  2. Basic Animal Models:
    Research utilizing basic animal models for aging studies has waned, with a shift towards more complex models that better mimic human aging and diseases.
  3. Isolated Studies on Single Age-Related Diseases:
    The journal has seen fewer publications that isolate studies on single diseases, as there is a growing trend towards understanding multi-morbidity and the interconnectedness of age-related conditions.

Similar Journals

CELL CYCLE

Leading Insights into Molecular and Developmental Biology.
Publisher: TAYLOR & FRANCIS INCISSN: 1538-4101Frequency: 24 issues/year

CELL CYCLE, an esteemed journal published by Taylor & Francis Inc., stands at the forefront of biological research, focusing on the intricate mechanisms of cell proliferation, molecular biology, and developmental biology. With an ISSN of 1538-4101 and an E-ISSN of 1551-4005, this journal has established its influence in the field with a commendable impact factor reflecting its rigorous peer-review process and high-quality publications. Notably, in 2023, it achieved a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in both Cell Biology and Developmental Biology, marking its vital role in advancing scientific understanding and innovation. Operating within a converged framework from 2002 to 2024, CELL CYCLE caters to a diverse audience of researchers, professionals, and students eager to explore contemporary findings and emerging trends. The journal's objective is to disseminate groundbreaking research that enhances our understanding of cellular mechanisms, fostering collaboration and innovation. Although not an open-access journal, it remains a premier source for those engaged in cell cycle research, and its contributions have significant implications for fields such as healthcare, biotechnology, and genetics.

npj Aging

Bridging research and policy for a healthier aging society.
Publisher: NATURE PUBL GROUPISSN: Frequency: 1 issue/year

npj Aging, published by Nature Publishing Group, is a pioneering journal dedicated to advancing our understanding of the biological, clinical, and social aspects of aging. With an E-ISSN of 2731-6068, this open-access journal aims to foster innovative research and interdisciplinary dialogue among scientists, clinicians, and policy-makers. As of its inception in 2023, the journal has quickly established itself within the scholarly community, ranking 15th in Medicine (Geriatrics and Gerontology) and 12th in Biochemistry, Genetics, and Molecular Biology focusing on Aging, reflecting a strong percentile standing in both categories. The journal provides a platform for disseminating important findings that address the complexities of aging, ensuring accessibility for a broader audience. Located at the Macmillan Building, 4 Crinan St, London, England, npj Aging aspires to be an essential resource for those seeking to enhance their understanding and contribute to the field of gerontology.

GeroScience

Pioneering Discoveries in Geriatric Health
Publisher: SPRINGERISSN: 2509-2715Frequency: 6 issues/year

GeroScience, published by Springer, is an esteemed open-access journal that focuses on the multidisciplinary field of aging research. Since its inception in 2017, the journal has quickly established itself as a leader in its field, achieving impressive Q1 quartile rankings across various categories, including Aging, Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, and Complementary and Alternative Medicine, as per 2023 evaluations. With a significant impact factor that underscores its influence and reach in academia, GeroScience aims to disseminate high-quality research that addresses the complex challenges and advancements related to aging. Its accessible publication format fosters greater dissemination of knowledge and encourages collaboration among researchers, practitioners, and students eager to contribute to the growing body of work on age-related health issues. As it continues to thrive, GeroScience remains a pivotal resource for anyone looking to stay at the forefront of aging research.

Cellular and Molecular Gastroenterology and Hepatology

Unlocking insights in gastrointestinal and liver diseases.
Publisher: ELSEVIER INCISSN: 2352-345XFrequency: 12 issues/year

Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.

Frontiers in Aging

Pioneering Insights into the Aging Process
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Aging is a leading academic journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the biological processes associated with aging. Established in 2020, this open-access journal aims to bridge the gap between various disciplines including genetics, molecular biology, and physiology, providing a multidisciplinary platform for researchers and clinicians alike. With a notable impact factor denoted by its Q2 quartile rankings in Aging, Genetics, and Molecular Biology, and a Q1 ranking in Physiology as of 2023, the journal is recognized for its contribution to the scientific community. Located in Lausanne, Switzerland, it is committed to promoting open discourse and publishing cutting-edge studies that address the complexities of aging and its implications for health and longevity. The journal’s editorial board, consisting of leading experts, ensures the rigorous peer-review process, maintaining high academic standards and fostering innovation in aging research.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Elevating the standards of molecular cell research.
Publisher: ELSEVIERISSN: 0167-4889Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH is a premier journal published by Elsevier, dedicated to advancing the fields of cell biology and molecular biology. Established in 1982, this influential journal has been at the forefront of scientific research and innovation, currently holding esteemed positions with a Q2 ranking in Cell Biology and a Q1 ranking in Molecular Biology for 2023, reflecting its commitment to high-quality scholarship. With an impressive impact factor, it ranks in the 82nd and 78th percentiles for Molecular Biology and Cell Biology, respectively, amongst its peers. Researchers, professionals, and students will find this journal to be an invaluable resource for exploring the latest discoveries and methodologies in the molecular mechanisms underlying cellular functions. Although it is not an open-access journal, the insights offered in its pages contribute significantly to the scientific community's understanding of cellular and molecular processes, ensuring it remains a vital platform for disseminating cutting-edge research.

FREE RADICAL BIOLOGY AND MEDICINE

Advancing Knowledge in Biochemistry and Medical Physiology
Publisher: ELSEVIER SCIENCE INCISSN: 0891-5849Frequency: 12 issues/year

FREE RADICAL BIOLOGY AND MEDICINE, published by Elsevier Science Inc, is a premier journal dedicated to the field of biochemistry and medical physiology. With an ISSN of 0891-5849 and an E-ISSN of 1873-4596, this journal stands out with its impressive ranking in the 2023 category quartiles: Q1 in Biochemistry and Q1 in Physiology (medical). Specifically, it has achieved a remarkable position of 29th out of 438 in Biochemistry and 8th out of 113 in Physiology, placing it firmly in the 93rd percentile of its field, as per Scopus rankings. Since its inception in 1987, the journal has focused on advancing the understanding of free radicals and their role in biological processes, encompassing a wide range of topics from oxidative stress to therapeutic applications. Although it does not currently offer open access, the journal's rigorous peer-review process and impactful research ensure that it remains a valuable resource for researchers and professionals seeking to explore the intricate relationships between free radicals and health. The journal's headquarters are located at STE 800, 230 Park Ave, New York, NY 10169, reflecting its esteemed place within the scientific community and commitment to high-quality research.

BIOGERONTOLOGY

Fostering Global Dialogue on Age-Related Mechanisms
Publisher: SPRINGERISSN: 1389-5729Frequency: 4 issues/year

BIOGERONTOLOGY, published by SPRINGER, is a premier journal dedicated to the interdisciplinary study of biological aging processes and their implications for health and longevity. With an ISSN of 1389-5729 and an E-ISSN of 1573-6768, this journal features cutting-edge research that addresses critical questions in the fields of aging, geriatrics, and gerontology. Ranking impressively in the top quartiles, particularly as Q1 in Gerontology, BIOGERONTOLOGY is recognized for its contributions to advancing the understanding of aging at both molecular and systemic levels. The journal’s rich repository of scholarly articles provides valuable insights for researchers, healthcare professionals, and students alike, fostering a deeper comprehension of age-related biological mechanisms. Although not an open-access journal, it is highly regarded with an impact factor that reflects its significant role in the academic community. The journal spans from 2000 to 2024, ensuring a broad historical context for its studies, and is based in the Netherlands, with its administrative office located at One New York Plaza, Suite 4600, New York, NY 10004, United States. Engaging with BIOGERONTOLOGY means joining a global dialogue on the science of aging and the implications it holds for humanity.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Elevating knowledge in cellular and molecular lung physiology.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 1040-0605Frequency: 12 issues/year

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.

REDOX REPORT

Unveiling the Science of Redox Reactions
Publisher: TAYLOR & FRANCIS LTDISSN: 1351-0002Frequency: 1 issue/year

REDOX REPORT is a peer-reviewed academic journal published by Taylor & Francis Ltd, focusing on the latest advancements in the fields of biochemistry, clinical biochemistry, and physiology. Since its inception in 1996 and transitioning to an Open Access model in 2018, this journal has aimed to disseminate high-quality research findings and foster discussions within the scientific community. Positioned in the Q2 quartile across several relevant categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, REDOX REPORT is recognized for its commitment to impactful research. The journal plays a crucial role in bridging the gap between fundamental biochemical research and its clinical applications, making it an essential resource for researchers, professionals, and students alike. With a consistent publication record extending to 2024, REDOX REPORT is dedicated to featuring cutting-edge studies that advance our understanding of redox biology, thereby contributing significantly to the ongoing dialogue in the life sciences.